JAMP CEFUROXIME DIN 02547201
Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: CEFUROXIME (CEFUROXIME AXETIL)
Available to quote
Health Canada record
| Active ingredient(s) | CEFUROXIME (CEFUROXIME AXETIL) 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DC02 CEFUROXIME |
| Original market date | 27-Sep-2024 |
| Current status date | 27-Sep-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFUROXIME (CEFUROXIME AXETIL)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02244393 | APO-CEFUROXIME | APOTEX INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Marketed |
| 02244394 | APO-CEFUROXIME | APOTEX INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Marketed |
| 02344823 | AURO-CEFUROXIME | AURO PHARMA INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Marketed |
| 02344831 | AURO-CEFUROXIME | AURO PHARMA INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Marketed |
| 02212307 | CEFTIN | SANDOZ CANADA INCORPORATED | Granules For Suspension | CEFUROXIME (CEFUROXIME AXETIL) 125 MG | Marketed |
| 02547198 | JAMP CEFUROXIME | JAMP PHARMA CORPORATION | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Marketed |
| 02212293 | CEFTIN - PWR 250MG/SACHET | GLAXOSMITHKLINE INC | Powder | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled Post Market |
| 02212277 | CEFTIN - TAB 250MG | GLAXOSMITHKLINE INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled Post Market |
| 02212285 | CEFTIN - TAB 500MG | GLAXOSMITHKLINE INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled Post Market |
| 02145286 | CEFTIN FOR ORAL SUSPENSION-PWS 250MG/PCK | GLAXO CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled Post Market |
| 01943049 | CEFTIN PWS 125MG/5ML | GLAXO CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME AXETIL) 125 MG | Cancelled Post Market |
| 00886890 | CEFTIN TAB 250MG | GLAXO CANADA INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled Post Market |
| 00886904 | CEFTIN TAB 500MG | GLAXO CANADA INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled Post Market |
| 02230127 | NOVO-CEFUROXIME | NOVOPHARM LIMITED | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled Pre Market |
| 02230125 | NOVO-CEFUROXIME | NOVOPHARM LIMITED | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 125 MG | Cancelled Pre Market |
| 02230126 | NOVO-CEFUROXIME | NOVOPHARM LIMITED | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled Pre Market |
| 02336448 | NU-CEFUROXIME | NU-PHARM INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled (Unreturned Annual) |
| 02336456 | NU-CEFUROXIME | NU-PHARM INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled (Unreturned Annual) |
| 02323125 | ORB-CEFUROXIME | ORBUS PHARMA INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled (Unreturned Annual) |
| 02323117 | ORB-CEFUROXIME | ORBUS PHARMA INC | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled (Unreturned Annual) |
| 02311453 | PRO-CEFUROXIME - 500 | PRO DOC LIMITEE | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled Post Market |
| 02242657 | RATIO-CEFUROXIME | TEVA CANADA LIMITED | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 500 MG | Cancelled Post Market |
| 02242656 | RATIO-CEFUROXIME | TEVA CANADA LIMITED | Tablet | CEFUROXIME (CEFUROXIME AXETIL) 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33106 | 2024-04-23 | Abbreviated New Drug Submission (ANDS) |